Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-07

Clinical Trial Update: P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing artemether-lumefantrine to chloroquine for uncomplicated Plasmodium knowlesi malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Chloroquine (chloroquine)

Snippet

Sponsor: Menzies School of Health Research | Conditions: Uncomplicated Knowlesi Malaria | Phase 3 | Status: COMPLETED